About HebeCell

HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases the company's mission is to contribute to the fields of regenerative medicine and immuno-oncology by developing cell-based therapeutics. It produces cancer-specific natural killer (NK) cells that are developing while suspended in a liquid solution within a bioreactor, allowing them to reproduce indefinitely.

Company Highlights
Year Founded

2016

icon-altEmployees

21

Location (HQ)

USA

Since Last Funding

3 years

Monthly Website Visitors

2.9K

icon-altTotal Investment Amt

$63M

Last Funding Round

Series A

icon-altMoM Headcount Growth

4.98%

icon-altYoY Headcount Growth

4.98%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Health Care

Biotechnology

Biotechnology Research

Medical